| Record ID | ia:pharmaceuticaldo0000anse_l9t4 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/pharmaceuticaldo0000anse_l9t4/pharmaceuticaldo0000anse_l9t4_marc.xml |
| Download MARC binary | https://www.archive.org/download/pharmaceuticaldo0000anse_l9t4/pharmaceuticaldo0000anse_l9t4_meta.mrc |
LEADER: 03591cam 22006374a 4500
001 ocm40881470
003 OCoLC
005 20181126221551.0
008 990128s1999 paua b 001 0 eng
010 $a 99017498
040 $aDNLM/DLC$beng$cDLC$dNLM$dUKM$dMUQ$dBTCTA$dYDXCP$dOCLCG$dDEBBG$dOCL$dKGN$dOCLCF$dIG#$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dOCLCA$dVTM$dOCLCQ
015 $aGBA002841$2bnb
016 7 $a100884132$2DNLM
019 $a992332256
020 $a0683305727
020 $a9780683305722
035 $a(OCoLC)40881470$z(OCoLC)992332256
042 $apcc
050 00 $aRS200$b.A57 1999
060 00 $a1999 K-704
060 10 $aQV 785$bA618i 1999
082 00 $a615/.1$221
100 1 $aAnsel, Howard C.,$d1933-
245 10 $aPharmaceutical dosage forms and drug delivery systems /$cHoward C. Ansel, Loyd V. Allen, Jr., Nicholas G. Popovich.
250 $a7th ed.
260 $aPhiladelphia, Pa. :$bLippincott-Williams & Wilkins,$c℗♭1999.
300 $ax, 595 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 00 $gSect. I.$tPrinciples of Dosage form Design and Development --$g1.$tIntroduction to Drugs and Pharmacy --$g2.$tNew Drug Development and Approval Process --$g3.$tDosage Form Design: Pharmaceutic and Formulation Considerations --$g4.$tDosage Form Design: Biopharmaceutic and Pharmacokinetic Considerations --$g5.$tCurrent Good Manufacturing Practices and Good Compounding Practices --$gSect. II.$tSolid Dosage Forms and Modified-Release Drug Delivery Systems --$g6.$tPowders and Granules --$g7.$tCapsules and Tablets --$g8.$tModified-Release Dosage Forms and Drug Delivery Systems --$gSect. III.$tSemi-Solid and Transdermal Systems --$g9.$tOintments, Creams, and Gels --$g10.$tTransdermal Drug Delivery Systems --$gSect. IV.$tPharmaceutical Inserts --$g11.$tSuppositories and Inserts --$gSect. V.$tLiquid Dosage Forms --$g12.$tSolutions --$g13.$tDisperse Systems --$gSect. VI.$tSterile Dosage Forms and Delivery Systems --$g14.$tParenterals --$g15.$tBiologicals --$g16.$tOphthalmic Solutions and Suspensions --$gSect. VII.$tNovel and Advanced Dosage Forms, Delivery Systems, and Devices --$g17.$tRadiopharmaceuticals --$g18.$tProducts of Biotechnology --$g19.$tNovel Dosage Forms and Drug Delivery Technologies.$gApp.$tSystems and Techniques of Pharmaceutical Measurement.
650 0 $aDrugs$xDosage forms.
650 0 $aDrug delivery systems.
650 12 $aDosage Forms.
650 22 $aDrug Delivery Systems.
650 6 $aMe dicaments$xFormes pharmaceutiques.
650 6 $aMe dicaments$xAdministration$xDispositifs.
650 7 $aDrug delivery systems.$2fast$0(OCoLC)fst00898667
650 7 $aDrugs$xDosage forms.$2fast$0(OCoLC)fst00898801
650 7 $aArzneiform$2gnd
650 7 $aPharmazeutische Technologie$2gnd
700 1 $aAllen, Loyd V.
700 1 $aPopovich, Nicholas G.
856 41 $3Table of contents$uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=009593729&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
938 $aBaker and Taylor$bBTCP$n99017498
938 $aIngram$bINGR$n9780683305722
938 $aYBP Library Services$bYANK$n1606586
029 1 $aAU@$b000014538387
029 1 $aAU@$b000022643409
029 1 $aDEBBG$bBV014011924
029 1 $aNLM$b100884132
029 1 $aNZ1$b2515250
029 1 $aYDXCP$b1606586
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 159 OTHER HOLDINGS